• About us
• Contact

Advertisement

Product › Details

siRNA therapeutic

	Next higher product group	pharmaceutical_o

Record changed: 2024-01-15

Advertisement

More documents for siRNA therapeutic

• [1] Silence Therapeutics plc. (2/5/24). "Press Release: Silence Therapeutics Announces Oversubscribed $120 Million Private Placement". London....
• [2] Novartis AG. (7/17/23). "Press Release: Novartis Builds on Neuroscience Pipeline and xRNA Platform Capabilities with Acquisition of DTx Pharma". Basel....
• [3] Aldena Therapeutics Inc.. (3/16/23). "Press Release: Aldena Therapeutics Accelerates Its Novel and Disruptive Approach to Immuno-Dermatology". Boston, MA....
• [4] Silence Therapeutics plc. (2/21/22). "Press Release: Silence Therapeutics Appoints Craig Tooman President and Chief Executive Officer. Mark Rothera Steps Down as President and CEO". London....
• [5] Novartis AG. (1/6/22). "Press Release: Novartis Announces Collaboration with Alnylam to Explore Targeted Therapy to Restore Liver Function". Basel....
• [6] Silence Therapeutics plc. (10/15/21). "Press Release: Silence Therapeutics and Hansoh Pharma Announce Collaboration to Develop Therapeutics Leveraging Silence’s mRNAi GOLD™ Platform". London & Shanghai....
• [7] Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces Collaboration with AstraZeneca to Discover and Develop siRNA Therapeutics for Cardiovascular, Renal, Metabolic and Respiratory Diseases". London....
• [8] Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces R&D Update". London....
• [9] Novartis AG. (1/6/20). "Press Release: Novartis Successfully Completes Acquisition of The Medicines Company, Adding a Potentially First-in-Class, Investigational Cholesterol-lowering Therapy Inclisiran". Basel....
• [10] Novartis AG. (1/6/20). "Press Release: Novartis Completes Tender Offer for All Outstanding Shares of The Medicines Company". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.